Tarsus Pharmaceuticals
TARS
TARS
253 hedge funds and large institutions have $3.17B invested in Tarsus Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 88 increasing their positions, 82 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 82
12% less capital invested
Capital invested by funds: $3.61B → $3.17B (-$439M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
253
Holding in Top 10
3
Calls
$19.2M
Puts
$14.6M
Top Buyers
| 1 | +$41.6M | |
| 2 | +$31.3M | |
| 3 | +$30.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$21.7M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$18.6M |
Top Sellers
| 1 | -$36.2M | |
| 2 | -$18.9M | |
| 3 | -$17.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$17M |
| 5 |
BlackRock
New York
|
-$16.6M |
